Delirium in the critically ill patient

被引：5
作者：
Lorenzo, Mario [1 ]
Aldecoa, Cesar [1 ]
Rico, Jesus [1 ]
机构：
[1] Hosp Univ Rio Hortega, Dept Anesthesia & Surg Crit Care, Dulzaina 2, Valladolid 47012, Spain
来源：
TRENDS IN ANAESTHESIA AND CRITICAL CARE | 2013年 / 3卷 / 05期
关键词：
Delirium; Antipsychotics; Risk factors; Intensive care; Treatment;
D O I：
10.1016/j.tacc.2013.05.005
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Delirium is defined as a condition of altered consciousness, which develops acutely and shows a fluctuating clinical course. Delirium is the most common manifestation of brain dysfunction in critically ill patients. Delirium is underestimated and its diagnosis is often missed unless specific diagnostic instruments like CAM-ICU are used. The appearance of delirium and its persistence is associated with worse outcomes in the ICU. Although the pathophysiology of delirium remains elusive, identifying its mechanisms will allow for the development of preventive measures and effective treatments. Non-pharmacological approaches decrease the duration of delirium episodes and thus should be encouraged. Pharmacological treatment traditionally includes antipsychotics such as haloperidol or quetiapine; however, their use lacks significant evidence. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码：257 / 264
页数：8
相关论文
共 96 条
[91]  
Skrobik Y., Bergeron N., Dumont M., Gottfried S., Olanzapine versus haloperidol: Treating delirium in a critical care setting, Intensive Care Med, 39, pp. 422-430, (2004)
[92]  
Girard T.D., Pandharipande P.P., Carson S.S., Schmidt G.A., Wright P.E., Canonico A.E., Et al., Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial, Crit Care Med, 38, pp. 428-437, (2010)
[93]  
Devlin J.W., Roberts R.J., Fong J.J., Skrobik Y., Riker R.R., Hill N.S., Et al., Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study, Crit Care Med, 38, pp. 419-427, (2010)
[94]  
Devlin J.W., Skrobik Y., Riker R.R., Hinderleider E., Roberts R.J., Fong J.J., Et al., Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: a posthoc analysis of a double-blind, randomized, placebo-controlled study, Crit Care, 15, (2011)
[95]  
Kato K., Akama F., Yamada K., Maehara M., Kimoto K., Takahashi Y., Et al., Blonanserin in the treatment of delirium, Psychiatry Clin Neurosci, 65, pp. 389-391, (2011)
[96]  
Devlin J., Skrobik Y., Antipsychotics for the prevention and treatment of delirium in the intensive care unit: What is their role?, Harv Rev Psychiatry, 19, pp. 59-67, (2011)
12345678910